Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Gossamer Bio Usa, Inc.

Clinical trials sponsored by Gossamer Bio Usa, Inc., explained in plain language.

Now part of Gossamer Bio, Inc. GOSS NASDAQ

A clinical-stage biopharmaceutical company developing therapies for pulmonary and inflammatory diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1

New inhaled drug shows promise for Long-Term control of rare lung disease

Disease control Recruiting now

This study looks at the long-term safety of an inhaled medication called seralutinib for people with pulmonary arterial hypertension (PAH), a serious condition where high blood pressure damages the arteries in the lungs. About 316 participants who finished a previous seralutinib …

Phase: PHASE3 • Sponsor: Gossamer Bio USA, Inc. • Aim: Disease control

Last updated Jul 31, 2026 00:00 UTC